Note: This is a recording of a webinar held on August 18, 2020.
With dozens of COVID-19 vaccine trials in development and updates changing daily, in this webinar, Dr. Carlos del Rio will discuss a few of the leading COVID-19 vaccine trials, the progress that has been made and next steps in the COVID-19 vaccine trial process. We will also explore the safety and efficacy of the COVID-19 vaccine trial process.
The course contains two modules: a content module and a resources and evaluation module. After accessing both modules, learners will earn a certificate of completion. When the certificate is available, learners will see a Certificate button on their dashboard.
This recording is approximately 90 minutes. There are no prerequisites. Participants will need a broadband internet connection (Google Chrome or Mozilla Firefox are preferred browsers) and computer speakers. For technical support, please contact email@example.com.
About the Trainer
Carlos del Rio, MD is the Executive Associate Dean for Grady Clinical Affairs and a Professor of Medicine in the Division of Infectious Diseases at Emory University School of Medicine. Until recently, he was the Hubert Professor and Chair of the Hubert Department of Global Health at the Rollins School of Public Health of Emory University. Dr. del Rio currently holds joint appointments as a professor of Epidemiology and as professor of Global Health at Rollins. He is also the Principal Investigator and co-Director of the Emory Center for AIDS Research and co-Principal Investigator of the Emory-CDC HIV Clinical Trials Unit. Carlos del Rio is currently appointed as the Foreign Secretary of the National Academy of Medicine.
He is a native of Mexico where he attended medical school at Universidad la Salle in Mexico City, graduating in 1983. His internal medicine and infectious diseases residencies were completed at Emory.
This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under grant number UB6HP31680, Public Health Training Centers for $4,348,992. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the U.S. Government.
By the end of this webinar, participants will be able to:
- describe the national COVID-19 vaccine trials currently in development.
- explain the progress that has been made in the COVID-19 vaccine trials.
By completing/passing this course, you will attain the certificate Certificate of Completion for Online Module
Your cart is empty